precision medicine
Dr. Maulik Purohit, clinical innovation lead for transformation at University Hospitals, examines tech strategies and the unique challenges of clinical genetics and pop health genomics.
HIMSS21
CEO and cofounder of InsightRX Sirj Goswami shares how precise dosage, determined for each patient, can improve healthcare and avoid unwanted outcomes.
2bPrecise CEO Assaf Halevy discusses how genomic information can be injected into the workflow to manage the treatment of the patient.
Joel Diamond, MD, CMO of 2bPrecise, discusses pharmacogenomics as a good entry point for providers in precision medicine, identifying the right medicine for better outcomes and patient satisfaction.
Deep Dive: By integrating social factors, genomics and medical histories, clinicians are better able to treat patients.
DayTwo's metagenomics and gut microbiome database helps connect diabetics and others with evidence-based "food-as-medicine" treatment regimens, explains Josh Stevens, the company's president.
Mark Jackson, VP at NantHealth, was at Health 2.0 looking for new opportunities to bring valuable cloud-based data to physicians at the point of care.
Andrew Rebhan, consultant at The Advisory Board, discusses new advances in artificial intelligence, biopsychosocial IT, internet of things, 3D printing, augmented reality and more.
Kalle Killar, deputy secretary general at the Ministry of Social Affairs in Estonia, says that nearly 20% of the country's citizens are gene donors, giving it a very valuable asset for implementing precision medicine.
Bryce Olson, healthcare strategist at Intel, shares his remarkable precision medicine survival story and how his work is empowering other cancer patients.